{"denoms":[{"counts":[{"groupId":"BG000","value":"241"},{"groupId":"BG001","value":"242"},{"groupId":"BG002","value":"483"}],"units":"Participants"}],"groups":[{"description":"Participants received atezolizumab, 1200 mg, Q3W as IV infusion on Day 1 of each 21-day cycle until unacceptable toxicity or PD whichever occurred first.","id":"BG000","title":"Atezolizumab"},{"description":"Participants received atezolizumab, 1200 mg, Q3W, as IV infusion and lurbinectedin, 3.2 mg/m\\^2, Q3W, as IV infusion on Day 1 of each 21-day cycle until unacceptable toxicity or PD whichever occurred first.","id":"BG001","title":"Atezolizumab+ Lurbinectedin"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"8.0","value":"66.0"},{"groupId":"BG001","spread":"7.6","value":"65.1"},{"groupId":"BG002","spread":"7.8","value":"65.5"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"90"},{"groupId":"BG001","value":"91"},{"groupId":"BG002","value":"181"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"151"},{"groupId":"BG002","value":"302"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"16"},{"groupId":"BG002","value":"32"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"210"},{"groupId":"BG001","value":"206"},{"groupId":"BG002","value":"416"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"15"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"35"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"31"},{"groupId":"BG001","value":"31"},{"groupId":"BG002","value":"62"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"4"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"199"},{"groupId":"BG001","value":"195"},{"groupId":"BG002","value":"394"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"22"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"}],"populationDescription":"Full Analysis Set (FAS) included all participants randomized into the randomized phase, regardless of whether or not the assigned study treatment was received. Analysis was performed on the randomized treatment arms."}